Global Interventional Cardiology and Peripheral Vacular Diseases - 2025 -2033
Global Interventional Cardiology and Peripheral Vascular Devices Market Size
The global interventional cardiology and peripheral vascular devices market reached US$ 20.11 billion in 2023, with a rise to US$ 21.58 billion in 2024, and is expected to reach US$ 41.17 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
Key Market Trends & Insights
Driver: Rising Incidence of Cardiovascular Diseases (CVDs)
The escalating global prevalence of cardiovascular diseases (CVDs) is a primary catalyst propelling the growth of the interventional cardiology and peripheral vascular devices market. CVDs, encompassing conditions such as coronary artery disease, heart failure, and peripheral artery disease, are now the leading cause of death worldwide. In 2022, CVDs were responsible for approximately 19.8 million deaths globally, reflecting a substantial increase from 12.4 million in 1990. This surge is attributed to factors like aging populations, urbanization, and lifestyle changes, including poor diet, physical inactivity, and tobacco use.
The increasing burden of CVDs necessitates timely and effective medical interventions. Minimally invasive procedures, facilitated by advanced interventional devices, offer significant advantages in treating these conditions. For instance, coronary stenting, angioplasty, and atherectomy procedures are essential for managing coronary artery disease, while peripheral vascular interventions address blockages in peripheral arteries. The demand for these procedures is expected to rise in tandem with the growing incidence of CVDs, thereby driving the market for related devices.
Furthermore, the projected increase in global CVD cases underscores the need for continued innovation and investment in interventional cardiology and peripheral vascular devices. As the prevalence of CVDs continues to rise, the market for these devices is anticipated to expand, offering opportunities for healthcare providers and manufacturers to meet the evolving needs of patients worldwide.
Restraint: High Device and Procedure Costs
The high costs associated with interventional cardiology and peripheral vascular devices, along with the procedures themselves, pose a significant challenge to market growth. Advanced technologies such as drug-eluting stents, specialized catheters, and imaging systems often come with substantial price tags, making them less accessible in cost-sensitive healthcare settings and emerging markets. As a result, high device and procedure costs continue to act as a barrier, particularly in lower-income regions, slowing the overall expansion of the interventional cardiology and peripheral vascular devices market.
Segmentation Analysis
The global interventional cardiology and peripheral vascular devices market is segmented based on product type, application, end-user, and region.
Treatment Type - The interventional catheters segment is estimated to have 32.8% of the interventional cardiology and peripheral vascular devices market share.
The interventional catheters segment is poised to dominate the interventional cardiology and peripheral vascular devices market due to its essential role in nearly all minimally invasive cardiovascular procedures. These catheters are critical for accessing, navigating, and treating vascular conditions. The growing adoption of advanced diagnostic and therapeutic techniques, such as intravascular ultrasound (IVUS) and fractional flow reserve (FFR) measurements, is driving demand for specialized catheters that enhance procedural precision and patient outcomes.
Additionally, continuous technological advancements improving catheter flexibility, durability, and imaging capabilities are expanding their use across a wider range of cardiovascular interventions. As cardiovascular disease prevalence rises globally and the shift toward minimally invasive treatments accelerates, interventional catheters remain indispensable tools, securing their leading position in the market.
Geographical Analysis
The North America Interventional cardiology and peripheral vascular devices market was valued at 39.7% market share in 2024
North America holds a leading position in the interventional cardiology and peripheral vascular devices market, driven by a combination of clinical demand, technological leadership, and strong healthcare infrastructure. The region, particularly the United States, faces a high and rising prevalence of cardiovascular and peripheral artery diseases, which fuels consistent demand for minimally invasive interventions. This is supported by advanced healthcare systems equipped with modern catheter labs and surgical centers capable of adopting and integrating the latest devices.
Major global players such as Medtronic, Abbott, and Boston Scientific are headquartered in the U.S., allowing North America to remain at the forefront of innovation with rapid development and commercialization of next-generation devices like drug-eluting stents, atherectomy systems, and bioresorbable scaffolds. For instance, in August 2025, Boston Scientific announced the initiation of a new clinical trial aimed at evaluating its Agent Drug-Coated Balloon (DCB) against the current standard of care.
Additionally, strategic mergers and acquisitions in the region have expanded product portfolios and consolidated market strength. Altogether, these factors ensure North America remains the most dominant and mature market for interventional cardiology and peripheral vascular devices.
Major Players
The major players in the interventional cardiology and peripheral vascular devices market include B. Braun Interventional Systems Inc., Boston Scientific Corporation, BD, Medtronic, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co., Ltd, TERUMO CORPORATION, Cook, Shenzhen MicroApproach Medical Technology Co., Ltd, and Biotronik, among others.
Key Developments:
The global interventional cardiology and peripheral vascular devices market reached US$ 20.11 billion in 2023, with a rise to US$ 21.58 billion in 2024, and is expected to reach US$ 41.17 billion by 2033, growing at a CAGR of 7.5% during the forecast period 2025-2033.
Key Market Trends & Insights
- North America accounted for approximately 40.2% of the global interventional cardiology and peripheral vascular devices market in 2023 and is expected to retain a significant market share throughout the forecast period.
- Asia Pacific is anticipated to be the fastest-growing region, supported by expanding healthcare infrastructure, increasing prevalence of cardiovascular diseases, and growing demand for minimally invasive procedures.
- By product type, the interventional catheters segment holds a dominant position due to its essential role in diagnostic and therapeutic cardiovascular interventions.
- Continuous technological advancements in catheter design, imaging, and delivery systems are expected to further drive market growth and procedural success rates.
- 2024 Market Size: USD 21.58 Billion
- 2033 Projected Market Size: USD 41.17 Billion
- CAGR (2025–2033): 7.5%
- North America: Largest market in 2023
- Asia Pacific: Fastest-growing market.
Driver: Rising Incidence of Cardiovascular Diseases (CVDs)
The escalating global prevalence of cardiovascular diseases (CVDs) is a primary catalyst propelling the growth of the interventional cardiology and peripheral vascular devices market. CVDs, encompassing conditions such as coronary artery disease, heart failure, and peripheral artery disease, are now the leading cause of death worldwide. In 2022, CVDs were responsible for approximately 19.8 million deaths globally, reflecting a substantial increase from 12.4 million in 1990. This surge is attributed to factors like aging populations, urbanization, and lifestyle changes, including poor diet, physical inactivity, and tobacco use.
The increasing burden of CVDs necessitates timely and effective medical interventions. Minimally invasive procedures, facilitated by advanced interventional devices, offer significant advantages in treating these conditions. For instance, coronary stenting, angioplasty, and atherectomy procedures are essential for managing coronary artery disease, while peripheral vascular interventions address blockages in peripheral arteries. The demand for these procedures is expected to rise in tandem with the growing incidence of CVDs, thereby driving the market for related devices.
Furthermore, the projected increase in global CVD cases underscores the need for continued innovation and investment in interventional cardiology and peripheral vascular devices. As the prevalence of CVDs continues to rise, the market for these devices is anticipated to expand, offering opportunities for healthcare providers and manufacturers to meet the evolving needs of patients worldwide.
Restraint: High Device and Procedure Costs
The high costs associated with interventional cardiology and peripheral vascular devices, along with the procedures themselves, pose a significant challenge to market growth. Advanced technologies such as drug-eluting stents, specialized catheters, and imaging systems often come with substantial price tags, making them less accessible in cost-sensitive healthcare settings and emerging markets. As a result, high device and procedure costs continue to act as a barrier, particularly in lower-income regions, slowing the overall expansion of the interventional cardiology and peripheral vascular devices market.
Segmentation Analysis
The global interventional cardiology and peripheral vascular devices market is segmented based on product type, application, end-user, and region.
Treatment Type - The interventional catheters segment is estimated to have 32.8% of the interventional cardiology and peripheral vascular devices market share.
The interventional catheters segment is poised to dominate the interventional cardiology and peripheral vascular devices market due to its essential role in nearly all minimally invasive cardiovascular procedures. These catheters are critical for accessing, navigating, and treating vascular conditions. The growing adoption of advanced diagnostic and therapeutic techniques, such as intravascular ultrasound (IVUS) and fractional flow reserve (FFR) measurements, is driving demand for specialized catheters that enhance procedural precision and patient outcomes.
Additionally, continuous technological advancements improving catheter flexibility, durability, and imaging capabilities are expanding their use across a wider range of cardiovascular interventions. As cardiovascular disease prevalence rises globally and the shift toward minimally invasive treatments accelerates, interventional catheters remain indispensable tools, securing their leading position in the market.
Geographical Analysis
The North America Interventional cardiology and peripheral vascular devices market was valued at 39.7% market share in 2024
North America holds a leading position in the interventional cardiology and peripheral vascular devices market, driven by a combination of clinical demand, technological leadership, and strong healthcare infrastructure. The region, particularly the United States, faces a high and rising prevalence of cardiovascular and peripheral artery diseases, which fuels consistent demand for minimally invasive interventions. This is supported by advanced healthcare systems equipped with modern catheter labs and surgical centers capable of adopting and integrating the latest devices.
Major global players such as Medtronic, Abbott, and Boston Scientific are headquartered in the U.S., allowing North America to remain at the forefront of innovation with rapid development and commercialization of next-generation devices like drug-eluting stents, atherectomy systems, and bioresorbable scaffolds. For instance, in August 2025, Boston Scientific announced the initiation of a new clinical trial aimed at evaluating its Agent Drug-Coated Balloon (DCB) against the current standard of care.
Additionally, strategic mergers and acquisitions in the region have expanded product portfolios and consolidated market strength. Altogether, these factors ensure North America remains the most dominant and mature market for interventional cardiology and peripheral vascular devices.
Major Players
The major players in the interventional cardiology and peripheral vascular devices market include B. Braun Interventional Systems Inc., Boston Scientific Corporation, BD, Medtronic, Teleflex Incorporated, Lepu Medical Technology (Beijing) Co., Ltd, TERUMO CORPORATION, Cook, Shenzhen MicroApproach Medical Technology Co., Ltd, and Biotronik, among others.
Key Developments:
- In May 2024, Abbott announced the launch of the XIENCE Sierra Everolimus-Eluting Coronary Stent System in India. As one of the newest additions to the trusted XIENCE stent family, XIENCE Sierra is now accessible to patients with blocked coronary arteries, offering advanced treatment options. Designed for complex coronary interventions, the system delivers exceptional safety and performance, empowering interventional cardiologists to navigate and treat even the most challenging cases with greater confidence.
1. MARKET INTRODUCTION AND SCOPE
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Application
2.5. Snippet by End-User
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Incidence of Cardiovascular Diseases (CVDs)
3.1.1.2. Technological Advancements
3.1.2. Restraints
3.1.2.1. High Device and Procedure Costs
3.1.2.2. Risk of Complications
3.1.3. Opportunity
3.1.3.1. Emerging Markets Growth
3.1.3.2. Expansion of Outpatient and Ambulatory Care
3.1.4. Impact Analysis
4. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Interventional Catheters*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Guidewires
5.4. Stents
5.5. Atherectomy Devices
5.6. PTCA Balloons
5.7. Chronic Total Occlusion Devices
5.8. Synthetic Surgical Grafts
5.9. Embolic Protection Devices
5.10. Others
6. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY APPLICATION
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
6.1.2. Market Attractiveness Index, By Application
6.2. Angioplasty*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Coronary Thrombectomy
6.4. Congenital Heart Defect Correction
6.5. Valvuloplasty
6.6. Percutaneous Valve Repair
6.7. Others
7. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END-USER
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ambulatory Surgical Centers
7.4. Others
8. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. U.K.
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. Brazil
8.4.6.2. Argentina
8.4.6.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. China
8.5.6.2. India
8.5.6.3. Japan
8.5.6.4. South Korea
8.5.6.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
10.1. B. Braun Interventional Systems Inc.*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.4.4. SWOT Analysis
10.2. Boston Scientific Corporation
10.3. BD
10.4. Medtronic
10.5. Teleflex Incorporated
10.6. Lepu Medical Technology (Beijing)Co., Ltd
10.7. TERUMO CORPORATION
10.8. Cook
10.9. Shenzhen MicroApproach Medical Technology Co., Ltd
10.10. Biotronik (LIST NOT EXHAUSTIVE)
11. ASSUMPTIONS AND RESEARCH METHODOLOGY
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
1.1. Objectives of the Report
1.2. Report Coverage & Definitions
1.3. Report Scope
2. EXECUTIVE INSIGHTS AND KEY TAKEAWAYS
2.1. Market Highlights and Strategic Takeaways
2.2. Key Trends and Future Projections
2.3. Snippet by Product Type
2.4. Snippet by Application
2.5. Snippet by End-User
2.6. Snippet by Region
3. DYNAMICS
3.1. Impacting Factors
3.1.1. Drivers
3.1.1.1. Rising Incidence of Cardiovascular Diseases (CVDs)
3.1.1.2. Technological Advancements
3.1.2. Restraints
3.1.2.1. High Device and Procedure Costs
3.1.2.2. Risk of Complications
3.1.3. Opportunity
3.1.3.1. Emerging Markets Growth
3.1.3.2. Expansion of Outpatient and Ambulatory Care
3.1.4. Impact Analysis
4. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: STRATEGIC INSIGHTS AND INDUSTRY OUTLOOK
4.1. Market Leaders and Pioneers
4.1.1. Emerging Pioneers and Prominent Players
4.1.2. Established leaders with largest largest-selling Brand
4.1.3. Market leaders with established products & Services
4.2. Latest Developments and Breakthroughs
4.3. Regulatory and Reimbursement Landscape
4.3.1. North America
4.3.2. Europe
4.3.3. Asia Pacific
4.3.4. South America
4.3.5. Middle East & Africa
4.4. Porter’s Five Force Analysis
4.5. Supply Chain Analysis
4.6. Patent Analysis
4.7. SWOT Analysis
4.8. Unmet Needs and Gaps
4.9. Recommended Strategies for Market Entry and Expansion
4.10. Pricing Analysis and Price Dynamics
5. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY PRODUCT TYPE
5.1. Introduction
5.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
5.1.2. Market Attractiveness Index, By Product Type
5.2. Interventional Catheters*
5.2.1. Introduction
5.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
5.3. Guidewires
5.4. Stents
5.5. Atherectomy Devices
5.6. PTCA Balloons
5.7. Chronic Total Occlusion Devices
5.8. Synthetic Surgical Grafts
5.9. Embolic Protection Devices
5.10. Others
6. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY APPLICATION
6.1. Introduction
6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
6.1.2. Market Attractiveness Index, By Application
6.2. Angioplasty*
6.2.1. Introduction
6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
6.3. Coronary Thrombectomy
6.4. Congenital Heart Defect Correction
6.5. Valvuloplasty
6.6. Percutaneous Valve Repair
6.7. Others
7. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET: BY END-USER
7.1. Introduction
7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
7.1.2. Market Attractiveness Index, By End-User
7.2. Hospitals*
7.2.1. Introduction
7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Ambulatory Surgical Centers
7.4. Others
8. GLOBAL INTERVENTIONAL CARDIOLOGY AND PERIPHERAL VASCULAR DEVICES MARKET REGIONAL MARKET ANALYSIS AND GROWTH OPPORTUNITIES
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
8.1.2. Market Attractiveness Index, By Region
8.2. North America
8.2.1. Introduction
8.2.2. Key Region-Specific Dynamics
8.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.2.6.1. U.S.
8.2.6.2. Canada
8.2.6.3. Mexico
8.3. Europe
8.3.1. Introduction
8.3.2. Key Region-Specific Dynamics
8.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.3.6.1. Germany
8.3.6.2. U.K.
8.3.6.3. France
8.3.6.4. Spain
8.3.6.5. Italy
8.3.6.6. Rest of Europe
8.4. South America
8.4.1. Introduction
8.4.2. Key Region-Specific Dynamics
8.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.4.6.1. Brazil
8.4.6.2. Argentina
8.4.6.3. Rest of South America
8.5. Asia-Pacific
8.5.1. Introduction
8.5.2. Key Region-Specific Dynamics
8.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
8.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
8.5.6.1. China
8.5.6.2. India
8.5.6.3. Japan
8.5.6.4. South Korea
8.5.6.5. Rest of Asia-Pacific
8.6. Middle East and Africa
8.6.1. Introduction
8.6.2. Key Region-Specific Dynamics
8.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
8.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
8.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End-User
9. COMPETITIVE LANDSCAPE AND MARKET POSITIONING
9.1. Competitive Overview and Key Market Players
9.2. Market Share Analysis and Positioning Matrix
9.3. Strategic Partnerships, Mergers & Acquisitions
9.4. Key Developments in Product Portfolios and Innovations
9.5. Company Benchmarking
10. COMPANY PROFILES
10.1. B. Braun Interventional Systems Inc.*
10.1.1. Company Overview
10.1.2. Product Portfolio
10.1.2.1. Product Description
10.1.2.2. Product Key Performance Indicators (KPIs)
10.1.2.3. Historic and Forecasted Product Sales
10.1.2.4. Product Sales Volume
10.1.3. Financial Overview
10.1.3.1. Company Revenue
10.1.3.2. Geographical Revenue Shares
10.1.3.3. Revenue Forecasts
10.1.4. Key Developments
10.1.4.1. Mergers & Acquisitions
10.1.4.2. Key Product Development Activities
10.1.4.3. Regulatory Approvals, etc.
10.1.4.4. SWOT Analysis
10.2. Boston Scientific Corporation
10.3. BD
10.4. Medtronic
10.5. Teleflex Incorporated
10.6. Lepu Medical Technology (Beijing)Co., Ltd
10.7. TERUMO CORPORATION
10.8. Cook
10.9. Shenzhen MicroApproach Medical Technology Co., Ltd
10.10. Biotronik (LIST NOT EXHAUSTIVE)
11. ASSUMPTIONS AND RESEARCH METHODOLOGY
11.1. Data Collection Methods
11.2. Data Triangulation
11.3. Forecasting Techniques
11.4. Data Verification and Validation
12. APPENDIX
12.1. About Us and Services
12.2. Contact Us
LIST OF TABLES
Table 1 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 7 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 9 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 11 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 14 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 15 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 16 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 18 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 23 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 26 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 27 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 28 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 B. Braun Interventional Systems Inc.: Overview
Table 34 B. Braun Interventional Systems Inc.: Product Portfolio
Table 35 B. Braun Interventional Systems Inc.: Key Developments
Table 36 Boston Scientific Corporation: Overview
Table 37 Boston Scientific Corporation: Product Portfolio
Table 38 Boston Scientific Corporation: Key Developments
Table 39 BD: Overview
Table 40 BD: Product Portfolio
Table 41 BD: Key Developments
Table 42 Medtronic: Overview
Table 43 Medtronic: Product Portfolio
Table 44 Medtronic: Key Developments
Table 45 Teleflex Incorporated: Overview
Table 46 Teleflex Incorporated: Product Portfolio
Table 47 Teleflex Incorporated: Key Developments
Table 48 Lepu Medical Technology (Beijing)Co., Ltd: Overview
Table 49 Lepu Medical Technology (Beijing)Co., Ltd: Product Portfolio
Table 50 Lepu Medical Technology (Beijing)Co., Ltd: Key Developments
Table 51 TERUMO CORPORATION: Overview
Table 52 TERUMO CORPORATION: Product Portfolio
Table 53 TERUMO CORPORATION: Key Developments
Table 54 Cook: Overview
Table 55 Cook: Product Portfolio
Table 56 Cook: Key Developments
Table 57 Shenzhen MicroApproach Medical Technology Co., Ltd: Overview
Table 58 Shenzhen MicroApproach Medical Technology Co., Ltd: Product Portfolio
Table 59 Shenzhen MicroApproach Medical Technology Co., Ltd: Key Developments
Table 60 Biotronik: Overview
Table 61 Biotronik: Product Portfolio
Table 62 Biotronik: Key Developments
Table 1 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 2 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 3 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 4 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 5 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2025, 2029 & 2033 (US$ Billion)
Table 6 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 7 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2025, 2029 & 2033 (US$ Billion)
Table 8 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 9 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2025, 2029 & 2033 (US$ Billion)
Table 10 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 11 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Region, 2025, 2029 & 2033 (US$ Billion)
Table 12 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, By Region, 2022-2033 (US$ Billion)
Table 13 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 14 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 15 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 16 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 17 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 18 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 19 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 20 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 21 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 22 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 23 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 24 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 25 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 26 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 27 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 28 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 29 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, By Product Type, 2022-2033 (US$ Billion)
Table 30 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, By Application, 2022-2033 (US$ Billion)
Table 31 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, By End-User, 2022-2033 (US$ Billion)
Table 32 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, By Country, 2022-2033 (US$ Billion)
Table 33 B. Braun Interventional Systems Inc.: Overview
Table 34 B. Braun Interventional Systems Inc.: Product Portfolio
Table 35 B. Braun Interventional Systems Inc.: Key Developments
Table 36 Boston Scientific Corporation: Overview
Table 37 Boston Scientific Corporation: Product Portfolio
Table 38 Boston Scientific Corporation: Key Developments
Table 39 BD: Overview
Table 40 BD: Product Portfolio
Table 41 BD: Key Developments
Table 42 Medtronic: Overview
Table 43 Medtronic: Product Portfolio
Table 44 Medtronic: Key Developments
Table 45 Teleflex Incorporated: Overview
Table 46 Teleflex Incorporated: Product Portfolio
Table 47 Teleflex Incorporated: Key Developments
Table 48 Lepu Medical Technology (Beijing)Co., Ltd: Overview
Table 49 Lepu Medical Technology (Beijing)Co., Ltd: Product Portfolio
Table 50 Lepu Medical Technology (Beijing)Co., Ltd: Key Developments
Table 51 TERUMO CORPORATION: Overview
Table 52 TERUMO CORPORATION: Product Portfolio
Table 53 TERUMO CORPORATION: Key Developments
Table 54 Cook: Overview
Table 55 Cook: Product Portfolio
Table 56 Cook: Key Developments
Table 57 Shenzhen MicroApproach Medical Technology Co., Ltd: Overview
Table 58 Shenzhen MicroApproach Medical Technology Co., Ltd: Product Portfolio
Table 59 Shenzhen MicroApproach Medical Technology Co., Ltd: Key Developments
Table 60 Biotronik: Overview
Table 61 Biotronik: Product Portfolio
Table 62 Biotronik: Key Developments
LIST OF FIGURES
Figure 1 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 4 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 5 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global Interventional Cardiology and Peripheral Vascular Devices Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 7 Interventional Catheters Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 8 Guidewires Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 9 Stents Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 10 Atherectomy Devices Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 11 PTCA Balloons Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 12 Chronic Total Occlusion Devices Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 13 Synthetic Surgical Grafts Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 14 Embolic Protection Devices Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 15 Others Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 16 Global Interventional Cardiology and Peripheral Vascular Devices Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 17 Angioplasty Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 18 Coronary Thrombectomy Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 19 Congenital Heart Defect Correction Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 20 Valvuloplasty Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 21 Percutaneous Valve Repair Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 22 Others Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 23 Global Interventional Cardiology and Peripheral Vascular Devices Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 24 Hospitals End-User in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 25 Ambulatory Surgical Centers End-User in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 26 Others End-User in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 27 Global Interventional Cardiology and Peripheral Vascular Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 28 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 29 North America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 30 North America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 31 North America Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 32 North America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 33 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 34 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 35 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 36 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 37 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 38 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 39 Europe Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 40 Europe Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 41 Europe Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 42 Europe Interventional Cardiology and Peripheral Vascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 43 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 44 South America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 45 South America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 46 South America Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 47 South America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 48 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 49 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 50 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 51 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 52 B. Braun Interventional Systems Inc.: Financials
Figure 53 Boston Scientific Corporation: Financials
Figure 54 BD: Financials
Figure 55 Medtronic: Financials
Figure 56 Teleflex Incorporated: Financials
Figure 57 Lepu Medical Technology(Beijing)Co., Ltd: Financials
Figure 58 TERUMO CORPORATION: Financials
Figure 59 Cook: Financials
Figure 60 Shenzhen MicroApproach Medical Technology Co., Ltd: Financials
Figure 61 Biotronik: Financials
Figure 1 Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 2 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 3 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 4 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 5 Global Interventional Cardiology and Peripheral Vascular Devices Market Share, By Region, 2024 & 2033 (%)
Figure 6 Global Interventional Cardiology and Peripheral Vascular Devices Market Y-o-Y Growth, By Product Type, 2023-2033 (%)
Figure 7 Interventional Catheters Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 8 Guidewires Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 9 Stents Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 10 Atherectomy Devices Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 11 PTCA Balloons Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 12 Chronic Total Occlusion Devices Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 13 Synthetic Surgical Grafts Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 14 Embolic Protection Devices Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 15 Others Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 16 Global Interventional Cardiology and Peripheral Vascular Devices Market Y-o-Y Growth, By Application, 2023-2033 (%)
Figure 17 Angioplasty Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 18 Coronary Thrombectomy Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 19 Congenital Heart Defect Correction Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 20 Valvuloplasty Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 21 Percutaneous Valve Repair Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 22 Others Application in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 23 Global Interventional Cardiology and Peripheral Vascular Devices Market Y-o-Y Growth, By End-User, 2023-2033 (%)
Figure 24 Hospitals End-User in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 25 Ambulatory Surgical Centers End-User in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 26 Others End-User in Global Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 27 Global Interventional Cardiology and Peripheral Vascular Devices Market Y-o-Y Growth, By Region, 2023-2033 (%)
Figure 28 North America Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 29 North America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 30 North America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 31 North America Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 32 North America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 33 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 34 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 35 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 36 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 37 Asia-Pacific Interventional Cardiology and Peripheral Vascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 38 Europe Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 39 Europe Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 40 Europe Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 41 Europe Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 42 Europe Interventional Cardiology and Peripheral Vascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 43 South America Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 44 South America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 45 South America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 46 South America Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 47 South America Interventional Cardiology and Peripheral Vascular Devices Market Share, By Country, 2024 & 2033 (%)
Figure 48 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Value, 2022-2033 (US$ Billion)
Figure 49 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Share, By Product Type, 2024 & 2033 (%)
Figure 50 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Share, By Application, 2024 & 2033 (%)
Figure 51 Middle East and Africa Interventional Cardiology and Peripheral Vascular Devices Market Share, By End-User, 2024 & 2033 (%)
Figure 52 B. Braun Interventional Systems Inc.: Financials
Figure 53 Boston Scientific Corporation: Financials
Figure 54 BD: Financials
Figure 55 Medtronic: Financials
Figure 56 Teleflex Incorporated: Financials
Figure 57 Lepu Medical Technology(Beijing)Co., Ltd: Financials
Figure 58 TERUMO CORPORATION: Financials
Figure 59 Cook: Financials
Figure 60 Shenzhen MicroApproach Medical Technology Co., Ltd: Financials
Figure 61 Biotronik: Financials
